Nanosonics Limited

ASX NAN.AX

Nanosonics Limited Price to Earnings Ratio (P/E) on January 14, 2025: 71.48

Nanosonics Limited Price to Earnings Ratio (P/E) is 71.48 on January 14, 2025, a 14.08% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Nanosonics Limited 52-week high Price to Earnings Ratio (P/E) is 91.15 on October 15, 2024, which is 27.51% above the current Price to Earnings Ratio (P/E).
Nanosonics Limited 52-week low Price to Earnings Ratio (P/E) is 39.28 on February 26, 2024, which is -45.06% below the current Price to Earnings Ratio (P/E).
Nanosonics Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 61.96.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

ASX: NAN.AX

Nanosonics Limited

CEO	Mr. Michael C. Kavanagh BSc, M.B.A.
IPO Date	May 17, 2007
Location	Australia
Headquarters	Building A
Employees	466
Sector	Health Care
Industries Biotechnology Medical Instruments

Description

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Key trends

Past 5 years